Financial News
Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval
June 07, 2021 at 20:21 PM EDT
"Desperation should drive funding for Alzheimer's research, it should not drive the interpretation of scientific evidence," Karlawish said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
